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Abstract 
Acyclovir is frequently used in the management of 
suspected or proven serious viral infections in children. 
Despite its good safety profile serious side effects are 
known to occur. We describe a case of suspected viral 
encephalitis treated with intravenous acyclovir and 
complicated by acute, reversible, renal failure. To our 
knowledge this is the first such report in a Maltese 
Paediatric patient. 
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Introduction  
Acyclovir is an effective antiviral drug. Its use is 
particularly important in proven or suspected Herpes or 
Varicella infections. Reports of adverse effects are 
uncommon and occur almost always in adults, with renal 
dysfunction and neurotoxicity being the most frequently 
reported.
1
 Adverse effects have been reported with both 
oral and intravenous administration of acyclovir as well 
as with slow or rapid intravenous administration of the 
drug.
2
 Adequate hydration is essential with acyclovir 
therapy to reduce the risk of drug induced renal damage. 
We report a case of non-oliguric acute renal failure with 
complete recovery in an eleven year old boy treated with 
acyclovir. 
 
 
 
 
Case report 
An eleven year old, previously well boy, presented 
to casualty following a prolonged first seizure. The 
patient remained confused and agitated in the postictal 
phase with a Glasgow coma scale (GCS) of 6. He had a 
mild viral-like illness in the preceding days. He was 
afebrile on admission. There were no rashes and as the 
patient was unconscious neck stiffness could not be 
assessed. Due to persistent irregular breathing the patient 
was transferred for further monitoring to the intensive 
care unit. A computerised tomography (CT) scan of the 
brain was normal as were initial biochemical and 
haematological investigations. No contrast was 
administered during the CT examination. Serum 
creatinine level on admission was 40umol/l. In view of 
the prolonged seizure a provisional diagnosis of 
suspected viral encephalitis was made and the patient 
was started on triple therapy with ceftriaxone, 
clarithromycin and acyclovir at a dose of 500mg/m
2
/8 
hourly. A lumbar puncture was postponed in view of the 
prolonged loss of consciousness. Fluid replacement was 
restricted to sixty percent of requirements in view of the 
possible encephalitis. Twelve hours post admission the 
patient’s level of consciousness improved. He was alert 
and no longer confused and was transferred to a general 
paediatric ward for further management. On day three 
post admission a routine renal profile revealed a serum 
creatinine level of 364umol/l. Electrolytes were normal 
and urea rose to 11.8mmol/l. Urine output remained 
good and blood pressure was on the 97
th
. Percentile for 
age. At this stage the possibility of acyclovir induced 
acute renal damage was considered. Renal ultrasound 
examination was normal. Examination of the urine under 
polarized light could not be performed as the 
investigation was not available locally. Hyperhydration 
(3 liters/m
2
/day) and diuretics (frusemide 1mg/kg/eight 
hourly) were started and a urine output of 4-6ml/kg/hour 
was maintained. Creatinine levels increased to 
450umol/l and subsequently 552umol/l on day two and 
three respectively. An elevated blood pressure was  
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treated with nifedipine 5mg twelve hourly. Acid base 
balance and electrolytes remained within normal. 
Following a maintained high urine output the patient’s 
creatinine level started to decrease from the end of day 
three. By day five his creatinine level had decreased to 
99umol/l, blood pressure normalised and his intravenous 
fluids were stopped. Outpatient review at three, seven 
and ten days following discharge was normal. Long term 
follow-up at three and six months did not reveal any 
abnormalities and renal function remained normal. 
 
Discussion 
The pharmacokinetics of acyclovir in children and 
adolescents are similar to those of adults.
3
 Acyclovir is 
generally well tolerated. Adverse effects associated with 
acyclovir in children and adults include nausea and/or 
vomiting (2-8%), diarrhoea (0.3-4%), headache or 
malaise (0.6-12% of patients), asthenia or paraesthesia 
(0.8-2%), and skin rash (0.3-2%). Additional adverse 
effects associated with intravenous infusions of 
acyclovir include local inflammation or phlebitis (9%), 
transient neutropaenia (3%), elevations in serum 
creatinine or urea (5-10%), and elevation of hepatic 
transaminases (1-2%).
4,5
 Recommended dosing regimen 
for children is 500mg/m
2
/eight hourly given by 
intravenous infusion over a one hour period. The kidney 
accounts for 75-80% of the total clearance of Acyclovir. 
In addition, acyclovir is relatively insoluble in the urine, 
particularly in the distal tubular lumen, where urine flow 
is sluggish. These characteristics explain why 
intravenous infusion of acyclovir may cause intra-
tubular precipitation of crystals in the kidney.
(6)
 
Adequate hydration is essential with intravenous use of 
acyclovir. Our patient was suspected of having viral 
encephalitis and his fluid replacement was restricted to 
sixty percent of requirements. This undoubtedly would 
have contributed to the crystallization and deposition of 
the drug in the renal tubules.  
Risk factors for acyclovir Nephrotoxicity include 
high blood concentration of acyclovir caused by doses 
greater than 1500mg/m
2
/day, rapid intravenous 
administration, pre-existing renal disease, dehydration 
and associated use of other nephrotoxic drugs.
7
 
Nephrotoxicity usually is a self-limiting condition that 
resolves with discontinuation of the drug and 
hyperhydration (3 liters/m2/day). Severe cases of renal 
failure may need hemodialysis. The risk of 
nephrotoxicty can be minimized by ensuring adequate 
hydration and a high urine flow and by giving acyclovir 
as a slow infusion rate over one hour.
8 
In patient with 
pre-existing renal disease, acyclovir dosage should be 
modified according to creatinine levels. 
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